Cat.#: ACPP-1079
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
| ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg | inquiry |
| ACPP-1533 | Human NREP Protein (AC1533) | 2 µg | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1465 | Human CHRNA3 Protein (AC1465) | 5 µg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
| ACPP-1485 | Rat VEGF C Protein (152 a.a.) (AC1485) | 2 µg | inquiry |
| ACPP-1739 | Human SYT3 Protein (AC1739) | 5 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.